<?xml version="1.0" encoding="UTF-8"?>
<p>More RVFV seroprevalence studies have been conducted in livestock species (77/174 [44.3%]) than humans (60/174 [34.5%]) or wildlife (40/174 [23%]). Over the last four decades 16/174 (9.2%) seroprevalence studies have been conducted in camels. All RVFV seroprevalence studies undertaken in wildlife species were conducted in IEPs and only in Zimbabwe, South Africa, Senegal and Botswana.</p>
